All Stories

  1. Mediastinitis in open heart surgery: a systematic review and meta-analysis of risk factors
  2. Early discharge compared with ordinary discharge after percutaneous coronary intervention – a systematic review and meta-analysis of safety and cost
  3. Latitude of the study place and age of the patient are associated with incidence of mediastinitis and microbiology in open-heart surgery: a systematic review and meta-analysis
  4. Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
  5. Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
  6. Obstructive sleep apnea in younger school children with Down syndrome
  7. Effects of omega 3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
  8. Improved Rate Control Reduces Cardiac Troponin T Levels in Permanent Atrial Fibrillation
  9. Hospitalization for Acute Otitis Media as a Useful Marker for Disease Severity
  10. Myocardial Salvage is Reduced in Primary PCI-Treated STEMI Patients with Microvascular Obstruction, Demonstrated by Early and Late CMR
  11. Otitis media with effusion in children with in Down syndrome
  12. Hearing level in children with Down syndrome at the age of eight
  13. Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
  14. Adrenoleukodystrophy in Norway: High Rate of De Novo Mutations and Age-Dependent Penetrance
  15. Comparison of Four Single-Drug Regimens on Ventricular Rate and Arrhythmia-Related Symptoms in Patients With Permanent Atrial Fibrillation
  16. Mediastinitis after coronary artery bypass grafting increases the incidence of left internal mammary artery obstruction
  17. Mediastinitis after coronary artery bypass grafting: the effect of vacuum-assisted closure versus traditional closed drainage on survival and re-infection rate
  18. Lung function and dyspnea in patients with permanent atrial fibrillation
  19. Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
  20. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: A cross-sectional study
  21. Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
  22. Amino-Terminal Pro–B-Type Natriuretic Peptide (NT-proBNP) Levels 3 Months After Myocardial Infarction Are More Strongly Associated With Magnetic Resonance–Determined Ejection Fraction Than NTproBNP Levels in the Acute Phase
  23. Mental Health and Sleep in Permanent Atrial Fibrillation Patients From the General Population
  24. Mediastinitis After Coronary Artery Bypass Grafting Risk Factors and Long-Term Survival
  25. The association between metabolic syndrome and infarct size in patients with acute myocardial infarction
  26. Antiepileptic drugs and quality of life in the elderly: Results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age
  27. Critical appraisal of case–control studies of risk factors or etiology of Hyperemesis gravidarum
  28. Rationale and Design of the POSTEMI (Postconditioning in ST-Elevation Myocardial Infarction) Study
  29. Guidelines' criteria for rate control in atrial fibrillation: Are they useful?
  30. Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances
  31. Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
  32. Helicobacter pyloriinfection and hyperemesis gravidarum: a systematic review and meta-analysis of case–control studies
  33. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
  34. Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case-control studies
  35. Gender Differences in Management and Outcome of Acute Myocardial Infarctions Treated in 2006–2007
  36. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
  37. Troponin T Concentration 3 Days after Acute ST-Elevation Myocardial Infarction Predicts Infarct Size and Cardiac Function at 3 Months
  38. Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation
  39. Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
  40. Helicobacter pylori infection and Hyperemesis gravidarum. An institution-based case–control study
  41. Observer variability in screen-film mammography versus full-field digital mammography with soft-copy reading
  42. Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation
  43. Less Benefit from Warfarin in Diabetics after Myocardial Infarction?
  44. The Predictive Value of Transthoracic Echocardiographic Variables for Sinus Rhythm Maintenance after Electrical Cardioversion of Atrial Fibrillation
  45. Mortality in childhood progressive encephalopathy from 1985 to 2004 in Oslo, Norway: a population-based study
  46. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized con...
  47. Atrial Fibrillation and Antithrombotic Therapy in a 75-Year-Old Population
  48. Candesartan in the prevention of relapsing atrial fibrillation
  49. Incidence rates of progressive childhood encephalopathy in Oslo, Norway: a population based study
  50. Effect of Candesartan and Various Inflammatory Markers on Maintenance of Sinus Rhythm After Electrical Cardioversion for Atrial Fibrillation
  51. The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation
  52. The NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction (NORDISTEMI)
  53. The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients
  54. Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
  55. The Impact of Bladder Filling and Time of Day on the Assessment of Genital Prolapse
  56. Effect of diet or very long chain ??-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima???media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia
  57. Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging
  58. Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty
  59. N-Terminal pro-B-Type Natriuretic Peptide in Risk Stratification after Acute Myocardial Infarction in Patients on Long-Term Beta-Adrenergic Receptor Blocker Therapy
  60. Bowel magnetic resonance imaging of pediatric patients with oral mannitol
  61. Insulin Sensitivity in Women with Coronary Heart Disease during Hormone Replacement Therapy
  62. MR imaging of the small bowel with increasing concentrations of an oral osmotic agent
  63. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects
  64. A Comparison of the Two β-Blockers Carvedilol and Atenolol on Left Ventricular Ejection Fraction and Clinical Endpoints after Myocardial Infarction
  65. 1118-77 Effects of carvedilol compared to atenolol on ejection fraction and clinical endpoints after myocardial infarction
  66. Unstable angina, stroke, myocardial infarction and death in aspirin non‐responders. A prospective, randomized trial. The ASCET (ASpirin non‐responsiveness and Clopidogrel Endpoint Trial) design
  67. Warfarin, Aspirin, or Both after Myocardial Infarction
  68. Leg Wound Closure after Saphenous Vein Harvesting in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Randomized Study Comparing Intracutaneous, Transcutaneous and Zipper Techniques
  69. Predictors of Restenosis after Coronary Angioplasty. A Study on Demographic and Metabolic Variables
  70. Lumbar Spinal Stenosis: Conservative or Surgical Management?
  71. Current Smokers Develop More Posterior Myocardial Infarctions Probably Due to Increased Tendency to Thrombosis
  72. n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study
  73. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia
  74. Infarct Size Is Reduced and the Frequency of Non-Q-Wave Myocardial Infarctions Is Increased in Patients Using Aspirin at the Onset of Symptoms
  75. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia
  76. Pressure Measurements in Herniated Lumbar Disks
  77. Evidence of Excess Hereditary Predisposition in Women with Angiographically Documented Coronary Artery Disease
  78. Use of Fish Oils Appears to Reduce Infarct Size as Estimated from Peak Creatine Kinase and Lactate Dehydrogenase Activities
  79. Thrombolytic therapy for acute myocardial infarction in older patients
  80. Risk of Toxoplasmic Encephalitis in AIDS Patients: Indications for Prophylaxis
  81. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
  82. Infarct size estimated from peak creatine kinase is reduced in patients using beta-blockers at the onset of chest pain
  83. Clinical Results After Percutaneous Automated Lumbar Nucleotomy
  84. Lumbar Spinal Stenosis
  85. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome
  86. Risk Factors for Graft Occlusion after Coronary Artery Bypass Grafting
  87. Clinical Results After Percutaneous Automated Lumbar Nucleotomy
  88. Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting
  89. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery
  90. Quality of Life after Kidney Transplantation. A 10–22 Years Follow-Up
  91. Growth Hormone Treatment and Development of Malignancy: Recombinant Human Growth Hormone Does not Induce Leukemia in AKR/O-Mice
  92. Long Term Morbidity and Mortality after Kidney Transplantation